West Pharmaceutical Services (WST) EBIAT (2016 - 2025)
Historic EBIAT for West Pharmaceutical Services (WST) over the last 17 years, with Q4 2025 value amounting to $132.1 million.
- West Pharmaceutical Services' EBIAT rose 153.73% to $132.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $493.7 million, marking a year-over-year increase of 20.3%. This contributed to the annual value of $493.7 million for FY2025, which is 20.3% up from last year.
- As of Q4 2025, West Pharmaceutical Services' EBIAT stood at $132.1 million, which was up 153.73% from $140.0 million recorded in Q3 2025.
- Over the past 5 years, West Pharmaceutical Services' EBIAT peaked at $188.5 million during Q2 2022, and registered a low of $89.8 million during Q1 2025.
- Its 5-year average for EBIAT is $141.4 million, with a median of $138.5 million in 2023.
- As far as peak fluctuations go, West Pharmaceutical Services' EBIAT soared by 11336.57% in 2021, and later plummeted by 3132.12% in 2022.
- Over the past 5 years, West Pharmaceutical Services' EBIAT (Quarter) stood at $147.7 million in 2021, then tumbled by 30.26% to $103.0 million in 2022, then surged by 33.01% to $137.0 million in 2023, then dropped by 5.04% to $130.1 million in 2024, then rose by 1.54% to $132.1 million in 2025.
- Its last three reported values are $132.1 million in Q4 2025, $140.0 million for Q3 2025, and $131.8 million during Q2 2025.